Assignee profile:

Vascular Biogenics, Ltd.

City:

Or Yehuda

Country:

Israel

Published Applications:

57

Last publication date:

2018-11-15

Patent Grants:

41

Last grant date:

2019-02-19

Top Inventors for applications by Vascular Biogenics, Ltd.

These are the the leading inventors for applications assigned to Vascular Biogenics, Ltd.:

Recent patent applications by Vascular Biogenics, Ltd.

Vascular Biogenics, Ltd. based in Or Yehuda, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2018-11-15 ✅ Patent 10,206,936 granted on 2019-02-19
US20180325928A1
Human necessities

Oxidized lipids and treatment or prevention of fibrosis

#2 | 2018-01-18
US20180015183A1
Human necessities

METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS

#3 | 2017-12-14 ✅ Patent 10,383,954 granted on 2019-08-20
US20170354746A1
Human necessities

Methods of inducing responsiveness to anti-angiogenic agent

#4 | 2017-08-31 ✅ Patent 9,968,622 granted on 2018-05-15
US20170246197A1
Human necessities

High-purity phospholipids

#5 | 2016-10-20 ✅ Patent 9,771,385 granted on 2017-09-26
US20160304544A1
Chemistry; metallurgy

Oxidized lipids

#6 | 2016-05-26
US20160143968A1
Human necessities

TREATMENT METHODS USING ADENOVIRUS

#7 | 2016-05-05 ✅ Patent 9,682,154 granted on 2017-06-20
US20160121001A1
Human necessities

Methods of inducing responsiveness to anti-angiogenic agent

#8 | 2015-04-23 ✅ Patent 9,403,887 granted on 2016-08-02
US20150111957A1
Chemistry; metallurgy

Endothelial cell-specific polynucleotides and use thereof

#9 | 2015-02-12 ✅ Patent 9,200,056 granted on 2015-12-01
US20150044280A1
Chemistry; metallurgy

FAS-chimera adenovirus vector

#10 | 2014-06-05
US20140155467A1
Chemistry; metallurgy

PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESIS

#11 | 2014-01-09 ✅ Patent 9,567,605 granted on 2017-02-14
US20140010785A1
Chemistry; metallurgy

Methods for use of a specific anti-angiogenic adenoviral agent

#12 | 2013-11-14 ✅ Patent 10,369,196 granted on 2019-08-06
US20130303595A1
Human necessities

Compositions and methods for treating glioblastoma GBM

#13 | 2013-10-17 ✅ Patent 8,916,378 granted on 2014-12-23
US20130272998A1
Human necessities

Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy

#14 | 2013-09-12 ✅ Patent 9,006,217 granted on 2015-04-14
US20130237720A1
Chemistry; metallurgy

High-purity phospholipids

#15 | 2013-08-29
US20130225525A1
Human necessities

Combined Treatment Utilizing VB-201

#16 | 2013-08-15 ✅ Patent 9,254,297 granted on 2016-02-09
US20130209555A1
Human necessities

Formulations and dosage forms of oxidized phospholipids

#17 | 2013-08-08
US20130203707A1
Chemistry; metallurgy

Oxidized Lipid Compounds and Uses Thereof

#18 | 2013-07-25 ✅ Patent 8,759,557 granted on 2014-06-24
US20130190523A1
Chemistry; metallurgy

Process for the preparation of oxidized phospholipids

#19 | 2013-07-04
US20130172294A1
Human necessities

Treatment with VB-201

#20 | 2013-06-20 ✅ Patent 8,802,875 granted on 2014-08-12
US20130158283A1
Chemistry; metallurgy

Process for the preparation of oxidized phospholipids

#21 | 2013-03-28 ✅ Patent 8,569,529 granted on 2013-10-29
US20130079540A1
Chemistry; metallurgy

High-purity phospholipids

#22 | 2013-01-10 ✅ Patent 8,835,398 granted on 2014-09-16
US20130011367A1
Chemistry; metallurgy

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

#23 | 2012-12-27 ✅ Patent 8,563,534 granted on 2013-10-22
US20120329757A1
Chemistry; metallurgy

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#24 | 2012-10-04
US20120252883A1
Human necessities

Method and Composition to Increase Radiation-Induced Tumor Therapeutic Effects

#25 | 2012-08-09 ✅ Patent 8,846,401 granted on 2014-09-30
US20120201790A1
Chemistry; metallurgy

Promoters exhibiting endothelial cell specificity and methods of using same

#26 | 2012-05-24
US20120130108A1
Chemistry; metallurgy

PROCESS FOR THE PREPARATION OF OXIDIZED PHOSPHOLIPIDS

#27 | 2011-12-29
US20110319479A1
Chemistry; metallurgy

POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA

#28 | 2011-10-13 ✅ Patent 8,415,318 granted on 2013-04-09
US20110251122A1
Human necessities

Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy

#29 | 2011-08-25
US20110207985A1
Chemistry; metallurgy

PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESIS

#30 | 2011-08-25 ✅ Patent 9,206,206 granted on 2015-12-08
US20110207703A1
Human necessities

Oxidized lipid compounds and uses thereof

#31 | 2011-08-18
US20110201677A1
Chemistry; metallurgy

PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME

#32 | 2011-08-11 ✅ Patent 8,999,960 granted on 2015-04-07
US20110195937A1
Chemistry; metallurgy

Oxidized thiophospholipid compounds and uses thereof

#33 | 2011-08-04 ✅ Patent 8,501,715 granted on 2013-08-06
US20110189212A1
Chemistry; metallurgy

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#34 | 2011-06-02 ✅ Patent 8,206,743 granted on 2012-06-26
US20110129511A1
Chemistry; metallurgy

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

#35 | 2011-04-28 ✅ Patent 8,158,611 granted on 2012-04-17
US20110097350A1
Chemistry; metallurgy

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#36 | 2010-12-16 ✅ Patent 8,124,800 granted on 2012-02-28
US20100317881A1
Chemistry; metallurgy

Process for the preparation of oxidized phospholipids

#37 | 2010-11-25
US20100298226A1
Chemistry; metallurgy

POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA

#38 | 2010-04-01
US20100081193A1
Chemistry; metallurgy

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

#39 | 2010-02-25 ✅ Patent 7,973,023 granted on 2011-07-05
US20100048515A1
Chemistry; metallurgy

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#40 | 2009-12-31 ✅ Patent 8,859,745 granted on 2014-10-14
US20090326052A1
Chemistry; metallurgy

Promoters exhibiting endothelial cell specificity and methods of using same

#41 | 2009-09-08 ✅ Patent 7,585,666 granted on 2009-09-08
US10490746
-

Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy

#42 | 2009-08-20 ✅ Patent 7,893,291 granted on 2011-02-22
US20090209775A1
Chemistry; metallurgy

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#43 | 2009-03-12
US20090068207A1
Human necessities

Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease

#44 | 2008-12-11 ✅ Patent 7,989,427 granted on 2011-08-02
US20080305088A1
Human necessities

Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy

#45 | 2008-10-23 ✅ Patent 7,902,176 granted on 2011-03-08
US20080261865A1
Chemistry; metallurgy

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#46 | 2007-12-13
US20070286845A1
Chemistry; metallurgy

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

#47 | 2007-10-09 ✅ Patent 7,279,459 granted on 2007-10-09
US10451370
-

Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis

#48 | 2007-05-17 ✅ Patent 7,807,847 granted on 2010-10-05
US20070112211A1
Chemistry; metallurgy

Process for the preparation of oxidized phospholipids

#49 | 2007-05-03 ✅ Patent 7,625,882 granted on 2009-12-01
US20070099868A1
Chemistry; metallurgy

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#50 | 2007-03-06 ✅ Patent 7,186,704 granted on 2007-03-06
US10718596
-

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#51 | 2006-09-14 ✅ Patent 8,039,261 granted on 2011-10-18
US20060204478A1
Human necessities

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

#52 | 2006-06-27 ✅ Patent 7,067,649 granted on 2006-06-27
US10135447
-

Promoters exhibiting endothelial cell specificity and methods of using same

#53 | 2005-12-08 ✅ Patent 7,504,388 granted on 2009-03-17
US20050272813A1
Chemistry; metallurgy

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#54 | 2005-09-08
US20050197283A1
Human necessities

Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease

#55 | 2005-08-25 ✅ Patent 8,071,740 granted on 2011-12-06
US20050186179A1
Chemistry; metallurgy

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

#56 | 2005-05-26 ✅ Patent 7,579,327 granted on 2009-08-25
US20050112110A1
Chemistry; metallurgy

Promoters exhibiting endothelial cell specificity and methods of using same

#57 | 2005-01-04 ✅ Patent 6,838,452 granted on 2005-01-04
US10445347
-

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

Also check out Vascular Biogenics Ltd.'s (Or Yehuda, Israel) applicant profile with 18 patent applications submitted.

AssigneeID:

3320 ⎘